12/08/2025
Exciting news forthcoming in the new year with the publication of this groundbreaking trial on reversal of cognitive decline using personalized precision medicine approach and targeting individualized therapies. We can't wait to see the final publication!
In his latest blog, Dr. Dale Bredesen highlights breakthroughs that reshaped what’s possible in Alzheimer’s prevention and care — from the Evanthea randomized controlled trial’s record cognitive improvements to powerful new blood-based biomarkers that help us “see it coming” much earlier.
He also shares significant progress in assisted living, including residents improving their cognition, successful treatment of atypical Alzheimer’s presentations once considered untreatable, measurable reductions in depression (PHQ-9), and a landmark case showing normalization of ASL MRI after a year on ReCODE.
Read the full recap: https://www.apollohealthco.com/heres-to-tw3/.